Health-related quality of life after chemotherapy for advanced germ cell tumors: A comparison of standard-dose and high-dose chemotherapy

International Journal of Urology

Volumn 11, Issue 7, 2004, Pages 542-546

  Miyake, Hideaki ^a   Muramaki, Mototsugu ^b   Eto, Hiroshi ^a   Kamidono, Sadao ^b   Hara, Isao ^b  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Germ cell tumor; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; EMOTIONAL STABILITY; FITNESS; GENERAL CONDITION; GERM CELL TUMOR; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PAIN; PATIENT MONITORING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL STATUS;

ADULT; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; GERMINOMA; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; TESTICULAR NEOPLASMS;

EID: 4043103390     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00839.x     Document Type: Article

References (20)

1. Einhorn LH, Donohue JP. Advanced testicular cancer: update for urologists. J. Urol. 1998; 160: 1964-9.
2. Nichols CR, Roth BJ, Loehrer PJ et al. Salvage chemotherapy for recurrent germ cell cancer. Semin. Oncol. 1994; 21: 102-8.
3. Motzer RJ, Sheinfeld J, Mazumdar M et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J. Clin. Oncol. 2000; 18: 2413-18.
4. Bokemer C, Schmoll HJ. Treatment of advanced germ cell tumors by dose intensified chemotherapy with haematopoietic growth factors or peripheral blood stem cells (PBSC). Eur. Urol. 1993; 23: 223-30.
5. Yamada Y, Hara I, Gohji K et al. Efficacy of first-line bleomycin, etoposide, and cisplatin chemotherapy for peripheral blood stem cell mobilization in patients with germ cell cancer. Int. J. Clin. Oncol 1998; 3: 147-51.
6. Hara I, Yamada Y, Miyake H et al. Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors. Anticancer Drug 1999; 10: 711-18.
7. Bokemeyer C, Kollmannsberger C, Meisner C et al. First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: a multivariate and matchedpair analysis. J. Clin. Oncol. 1999; 17: 3450-6.
8. Tamburini M, Filiberti A, Barbieri A et al. Psychological aspects of testis cancer therapy: a prospective study. J. Urol. 1989; 142: 1487-95.
9. Douchez J, Droz JP, Desclaux B et al. Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors. J. Urol. 1993; 149: 498-504.
10. Stuart NS, Grundy R, Woodroffe CM, Cullen MH. Quality of life after treatment for testicular cancer - the patient's view. Eur. J. Cancer 1990; 26: 291-6.
11. Arai Y, Kawakita M, Hida S, Terachi T, Okada Y, Yoshida O. Psychosocial aspects in long-term survivors of testicular cancer. J. Urol. 1996; 155: 574-8.
12. Heidenreich A, Hofmann R. Quality-of-life issues in the treatment of testicular cancer. World J. Urol. 1999; 17: 230-8.
13. Hara I, Miyake H, Hara S et al. Health-related quality of life after radical cystectomy for bladder cancer: comparison of ileal conduit and orthotopic bladder replacement. BJU Int. 2002; 89: 10-13.
14. Ware JE, Snow KK, Kosinski M et al. SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute, New England Medical Center, Boston, 1993.
15. Hermeren G. Surgery, cancer and quality of life: ethical aspects. Scand. J. Urol. Nephrol. 1992; 142 (Suppl.): 15-18.
16. Gritz ER, Wellisch DK, Landsverk JA. Psychosocial sequelae in long-term survivors of testicular cancer. J. Psychosocial Oncol. 1988; 6: 41-5.
17. Mourits MJ, Bockermann I, de Vries EG et al. Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. Br. J. Cancer 2002; 86: 1546-50.
18. Vellenga E, van Agthoven M, Croockewit AJ et al. Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstruction, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study. Br. J. Haematol. 2001; 114: 319-26.
19. Macquart-Moulin G, Viens P, Palangie T et al. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment? J. Clin. Oncol. 2000; 18: 754-64.
20. Gulbrandsen N, Wisloff F, Brinch L et al. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood-stemcell support. Med. Oncol. 2001; 18: 65-77.